Manni Gianluca, Oddone Francesco, Parisi Vincenzo, Tosto Adriana, Centofanti Marco
Biopathology Department, University of Tor Vergata, Rome, Italy.
Prog Brain Res. 2008;173:25-30. doi: 10.1016/S0079-6123(08)01103-5.
From the results of the Ocular Hypertension Treatment Study emerged the conclusion that ocular hypertensive subjects with thinner central corneal thickness (CCT) are at increased risk of developing glaucoma. Although possible underlying biases that could have led to this conclusion are still under investigation, there is an increasing interest in the scientific community to understand the potential mechanisms of this increased risk profile. It has been proposed that interindividual differences in CCT might be purely responsible for inaccuracies of the tonometric readings with potential underestimation of the true IOP in subjects with thinner CCT although it is becoming progressively clearer that the true IOP is unpredictable with linear correction formulas for CCT, and it is likely that other material properties of the cornea contribute, together with CCT, to the tonometric artifact. Recently, it has become possible to measure the biomechanical properties of the cornea in vivo and it has been suggested that differences in corneal biomechanics may be the expression of interindividual structural differences of the ocular tissues (including lamina cribrosa), with potential consequences on the interindividual susceptibility to the glaucomatous damage under the same IOP level. A possible underlying biological risk related to thinner CCTs, independent of the influence on tonometric reading, has been proposed and largely studied after the results of the OHTS were published. Besides the understanding of the mechanism underlying the role of CCT as a risk factor for the development of glaucoma, it is important to understand how the information about CCT should be integrated in the clinical management of both ocular hypertension (OHT) and glaucoma and whether other ocular properties should be measured to better understand the individual risk profile.
中央角膜厚度(CCT)较薄的高眼压受试者患青光眼的风险增加。尽管可能导致这一结论的潜在偏差仍在调查中,但科学界对了解这种风险增加的潜在机制的兴趣与日俱增。有人提出,CCT的个体差异可能纯粹是导致眼压测量读数不准确的原因,对于CCT较薄的受试者,可能会低估真实眼压,尽管越来越清楚的是,使用CCT的线性校正公式无法预测真实眼压,而且角膜的其他材料特性可能与CCT一起导致眼压测量假象。最近,已经能够在体内测量角膜的生物力学特性,有人提出角膜生物力学的差异可能是眼组织(包括筛板)个体结构差异的表现,在相同眼压水平下,可能会对个体对青光眼损伤的易感性产生影响。在眼压升高治疗研究结果发表后,有人提出并大量研究了与较薄CCT相关的一种潜在生物学风险,该风险独立于对眼压测量读数的影响。除了了解CCT作为青光眼发生风险因素的潜在机制外,了解在高眼压(OHT)和青光眼的临床管理中应如何整合有关CCT的信息,以及是否应测量其他眼部特性以更好地了解个体风险状况也很重要。